These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706 [TBL] [Abstract][Full Text] [Related]
9. The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function. Brady OA; Zheng Y; Murphy K; Huang M; Hu F Hum Mol Genet; 2013 Feb; 22(4):685-95. PubMed ID: 23136129 [TBL] [Abstract][Full Text] [Related]
10. Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice. Feng T; Mai S; Roscoe JM; Sheng RR; Ullah M; Zhang J; Katz II; Yu H; Xiong W; Hu F EMBO Rep; 2020 Oct; 21(10):e50219. PubMed ID: 32852886 [TBL] [Abstract][Full Text] [Related]
11. The FTLD Risk Factor TMEM106B Regulates the Transport of Lysosomes at the Axon Initial Segment of Motoneurons. Lüningschrör P; Werner G; Stroobants S; Kakuta S; Dombert B; Sinske D; Wanner R; Lüllmann-Rauch R; Wefers B; Wurst W; D'Hooge R; Uchiyama Y; Sendtner M; Haass C; Saftig P; Knöll B; Capell A; Damme M Cell Rep; 2020 Mar; 30(10):3506-3519.e6. PubMed ID: 32160553 [TBL] [Abstract][Full Text] [Related]
12. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III. Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479 [TBL] [Abstract][Full Text] [Related]
13. The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death. Suzuki H; Matsuoka M J Biol Chem; 2016 Oct; 291(41):21448-21460. PubMed ID: 27563066 [TBL] [Abstract][Full Text] [Related]
14. Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease. Perneel J; Rademakers R Acta Neuropathol; 2022 Nov; 144(5):807-819. PubMed ID: 36056242 [TBL] [Abstract][Full Text] [Related]
16. Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice. Klein ZA; Takahashi H; Ma M; Stagi M; Zhou M; Lam TT; Strittmatter SM Neuron; 2017 Jul; 95(2):281-296.e6. PubMed ID: 28728022 [TBL] [Abstract][Full Text] [Related]
17. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain. Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750 [TBL] [Abstract][Full Text] [Related]
18. A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination. Feng T; Sheng RR; Solé-Domènech S; Ullah M; Zhou X; Mendoza CS; Enriquez LCM; Katz II; Paushter DH; Sullivan PM; Wu X; Maxfield FR; Hu F Brain; 2020 Jul; 143(7):2255-2271. PubMed ID: 32572497 [TBL] [Abstract][Full Text] [Related]
19. Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a). Brady OA; Zhou X; Hu F J Biol Chem; 2014 Jul; 289(28):19670-80. PubMed ID: 24872421 [TBL] [Abstract][Full Text] [Related]